- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03163693
The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG
May 20, 2017 updated by: General Hospital of Ningxia Medical University
The Effects of Dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in Patients Undergoing Off-pump Coronary Artery Bypass Grafting
The purpose of this study is to observe the impact of dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in patients undergoing off-pump coronary artery bypass Grafting.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Dexmedetomidine is a highly selective α2-adrenoceptor agonist used as a sedative or adjuvant anesthetic drug in clinical settings.From clinical observation, dexmedetomidine has been revealed to reduce the incidence of cardiovascular adverse events in patients with heart diseases during non-cardiac surgeries.Therefore, the aim of this sudy is to observe the impact of dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in patients during cardiac surgeries.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ningxia
-
Yinchuan, Ningxia, China, 750004
- General Hospital of Ningxia Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing off - pump coronary artery bypass grafting
- ASA physical status III-IV
- Aged 40-70 years
- NYHA physical status II-III
Exclusion Criteria:
- Bradycardia
- Atrioventricular block
- Echocardiography suggested:LVEF <40%, LVED>65mm
- Allergic to the drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group dexmedetomidine
20 eligible patients are received 0.5ug/kg dexmedetomidine intravenously 15 minutes before surgery
|
receive dexmedetomidine 0.5 μg/kg
Other Names:
|
Placebo Comparator: Group control
20 eligible patients are received equal volumes normal saline intravenously 15 minutes before surgery
|
receive equal volume of normal saline
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of cardiac troponin I at preoperative, postoperative,and 24 hours after surgery.
Time Frame: At preoperative, postoperative,and 24 hours after surgery.
|
Blood samples were sampled at preoperative, postoperative,and 24 hours after surgery for the cTnI,which were analyzed by using enzyme linked immunosorbent assay (ELISA).
|
At preoperative, postoperative,and 24 hours after surgery.
|
Change of Glycogen Phosphorylase Isoenzyme BB at preoperative, postoperative,and 24 hours after surgery.
Time Frame: At preoperative, postoperative,and 24 hours after surgery.
|
Blood samples were sampled at preoperative, postoperative,and 24 hours after surgery for the GP-BB,which were analyzed by using enzyme linked immunosorbent assay (ELISA).
|
At preoperative, postoperative,and 24 hours after surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Zhu Di, General Hospital of Ningxia Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2016
Primary Completion (Actual)
May 1, 2017
Study Completion (Anticipated)
May 1, 2017
Study Registration Dates
First Submitted
May 15, 2017
First Submitted That Met QC Criteria
May 20, 2017
First Posted (Actual)
May 23, 2017
Study Record Updates
Last Update Posted (Actual)
May 23, 2017
Last Update Submitted That Met QC Criteria
May 20, 2017
Last Verified
May 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Hypnotics and Sedatives
- Dexmedetomidine
Other Study ID Numbers
- 2015-NW-028
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
safety
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Bypass, Off-Pump
-
Peking University Third HospitalNot yet recruitingCoronary Artery Bypass, Off-PumpChina
-
Peking University Third HospitalRecruitingCoronary Artery Bypass, Off-PumpChina
-
University Medical Center GroningenTerminated
-
Pluromed, Inc.UnknownOff Pump Coronary Artery Bypass SurgeryGermany
-
University Hospital, GhentCAS Medical Systems, Inc.; Belgian Foundation for Cardiac SurgeryCompletedElective Off-pump Coronary Artery Bypass GraftingBelgium
-
Chinese Academy of Medical Sciences, Fuwai HospitalCompletedOff Pump Coronary Artery Bypass SurgeryChina
-
Assiut UniversityUnknownAcute Normovolemic Hemodilution | Off-Pump Coronary Artery Bypass SurgeryEgypt
-
Samsung Medical CenterCompletedOff Pump Coronary Artery Bypass GraftKorea, Republic of
-
Yonsei UniversityCompletedOff Pump Coronary Artery Bypass SurgeryKorea, Republic of
-
Chinese Academy of Medical Sciences, Fuwai HospitalUnknownCoronary Artery Disease | Aspirin | Off-pump Coronary Artery BypassChina
Clinical Trials on dexmedetomidine
-
Cairo UniversityUnknownSpinal Anesthesia DurationEgypt
-
Guangzhou Women and Children's Medical CenterCompletedAmbulatory Surgical ProceduresChina
-
The First Affiliated Hospital with Nanjing Medical...CompletedPostoperative Pain | Breast Feeding | Analgesia ObstetricalChina
-
Seoul National University Bundang HospitalCompleted
-
Guangzhou General Hospital of Guangzhou Military...CompletedPharmacodynamic InteractionChina
-
University Hospital DubravaRecruitingAortic Valve Stenosis | Systemic Inflammatory ResponseCroatia
-
Guangzhou General Hospital of Guangzhou Military...Completed
-
First Affiliated Hospital, Sun Yat-Sen UniversityUnknownArteriovenous MalformationChina
-
Guangzhou General Hospital of Guangzhou Military...UnknownCombined Spinal-epidural AnesthesiaChina
-
Eye & ENT Hospital of Fudan UniversityCompletedAgitated; State, Acute Reaction to StressChina